Chiral self-assembly of triorganotin complexes: Syntheses, characterization, crystal structures and antitumor activity of organotin(IV) complexes containing (R)-(+)-methylsuccinic acid, (S)-(+)-methylglutaric acid and l-(−)-malic acid ligands

Six new chiral triorganotin(IV) complexes, {(R₃Sn)₂[C₃H₆(COO)₂]}_n (R = Me: 1; Bu: 2), {(R₃Sn)₂[C₄H₈(COO)₂]}_n (R = Me: 3; Bu: 4), and {(R₃Sn)₂[C₂H₄O(COO)₂]}_n (R = Me: 5; Bu: 6) have been prepared by treatment of (R)-(+)-methylsuccinic acid, (S)-(+)-methylglutaric acid and l-(−)-malic acid, with the corresponding R₃SnCl (R = Me, Bu) and sodium ethoxide in methanol. All the complexes were characterized by elemental analysis, FT-IR, NMR (¹H, ¹³C, ¹¹⁹Sn) spectroscopy and TGA. Except for 3, all of the complexes were also characterized by X-ray crystallography. The structural analyses reveal that complexes 1 and 5 have 2D network structures in which (R)-(+)-methylsuccinic acid and l-(−)-malic acid act as tetradentate ligands coordinated to trimethyltin(IV) ions. Complexes 2 and 4 have 3D metal-organic framework structures in which the deprotoned acids serve as tetradentate ligands. Complex 6 adopts a 1D zigzag chain structure and forms a 2D supramolecular framework through intermolecular C-H?O interactions. In addition, the antitumor activities of complexes 1-6 have been studied. We also have measured the specific rotation of the chiral dicarboxylic acids and the organotin derivatives.     

(+)-Cystothiazole G: isolation and structural elucidation

Palladium-catalyzed cyclization-methoxycarbonylation of (2R,3S)-3-methylpent-4-yne-1,2-diol (6) derived from (2R,3S)-epoxybutanoate 5 followed by methylation gave the tetrahydro-2-furylidene acetate (−)-7, which was converted to the left-half aldehyde (+)-3. A Wittig reaction between (+)-3 and the phosphoranylide derived from the bithiazole-type phosphonium iodide 4 using lithium bis(trimethylsilyl)amide afforded the (+)-cystothiazole G (2), whose spectral data were identical with those of the natural product (+)-2. Thus, the stereochemistry of cystothiazole G (2) was proved to be (4R,5S,6(E)).     

New total synthesis of (+)-cystothiazole A based on palladium-catalyzed cyclization-methoxycarbonylation

Palladium-catalyzed cyclization-methoxycarbonylation of (2R,3S)-3-methylpenta-4-yne-1,2-diol (6) derived from (2R,3S)-epoxy butanoate 7 followed by methylation gave the tetrahydro-2-furylidene acetate (−)-10, which was converted to the left-half aldehyde (+)-3. A Wittig reaction between (+)-4 and the phosphoranylide derived from the bithiazole-type phosphonium iodide 4 using lithium bis(trimethylsilyl)amide afforded the (+)-cystothiazole A (2).     

Methyl 3-bromomethyl-3-butenoate as an isopentane building block for the stereoselective preparation of (S)-4-methyl-3,6-dihydro-2H-pyran-2-carbaldehyde and (+)-faranal

(S)-4-Methyl-3,6-dihydro-2H-pyran-2-carbaldehyde (3), the common intermediate in the syntheses of the C17-C27 subunit of laulimalide (4) and (+)-faranal (5), the trail pheromone of the pharaoh ant, Monomorium pharaonis, were obtained via transformation of methyl 3-bromomethyl-3-butenoate (1) into allylstannane 2 and subsequent allylation of (benzyloxy)acetaldehyde (6) in accordance with the Keck procedure as the key steps.     

Stereoselective synthesis of tetrahydroisoquinoline alkaloids: (−)-trolline, (+)-crispin A, (+)-oleracein E

Tetrahydroisoquinoline alkaloids, (S)-(−)-trolline, (R)-(+)-crispin A, and (R)-(+)-oleracein E, have been synthesized stereoselectively from the both enantiomers of common intermediate (S)-4 and (R)-4. The key step in the synthesis include a stereoselective Bi(OTf)₃-catalyzed intramolecular 1,3-chirality transfer reaction of chiral non-racemic amino allylic alcohols (S)-6 and (R)-6 to construct both enantiomers of (E)-1-propenyl tetrahydroisoquinoline 4.     

Temporary thio-derivatization in the synthesis of (+)-4-acetylbromoxone

A stereocontrolled synthesis of the marine natural products (+)-bromoxone (1) and (+)-4-acetylbromoxone (2) is reported. The sequence features the enzymatic kinetic resolution of 4-hydroxycyclohexenone (6) via its S-benzyl adduct. Thereafter, a base-mediated elimination-silylation generated an optically active (−)-4S-4-tert-butyldimethylsilyoxycyclohexenone (5), which then underwent diastereoselective epoxidation. Saegusa-Ito oxidation enabled formation of the corresponding α,β-unsaturated ketone 13. Bromination-elimination and subsequent removal of the silicon protecting group afforded (+)-bromoxone (1) which was converted into (+)-(4S,5R,6R)-4-acetoxy-2-bromo-5,6-epoxycyclohex-2-enone (2) [(+)-4-acetylbromoxone]. Using a luciferase gene reporter assay ED₅₀ for NFκB inhibition of 9 μM was determined.     

Chiral organotin (IV) carboxylates complexes: Syntheses, characterization, and crystal structures with chiral (S)-(+)-6-methoxy-α-methyl-2-naphthaleneaceto acid ligand

Eight new organotin (IV) carboxylates, (R₃Sn)₄(nap)₄ (R = Me 1, n-Bu 2), [(R₃Sn) (nap)]_n (R = Ph 3, PhCH₂4), (R₂Sn) (nap)₂ (R = n-Bu 5, Ph 6, PhCH₂7) and {[R₂Sn(nap)]₂O}₂ (R = Me 8) (nap = (S)-(+)-6-methoxy-α-methyl-2-naphthaleneaceto anion) have been synthesized. All of the complexes have been characterized by elemental analysis, FT-IR, NMR (¹H, ¹³C and ¹¹⁹Sn) spectra. Among these complexes, complexes 1, 3, 5 and 8 were also characterized by X-ray crystallography diffraction analysis, and the data of X-ray crystallography diffraction indicated that complexes 1, 3 and 5 are new chiral organotin (IV) carboxylates complexes. The structural analyses show that complex 1 has a tetranuclear Sn₄O₈ macrocycle structure, complex 3 has a 1D spring-like chiral helical chain with a columnar channel, complex 5 possesses a dimer structure, and complex 8 has a supramolecular chainlike ladder structure through weak intermolecular non-covalent O^…O interactions.     

Quantitative determination of conformational equilibrium in quinolizidine-piperidine alkaloids. Part 2: Synthesis and conformational study of N-methylalbine

N-methylalbine (5) was synthesized for the first time. The structure is other than the one bearing hitherto its name. The fraction of the conformer with the boat ring C in the conformational equilibrium in 5 in benzene solution was determined to be ca. 22% using coupling constant J_9-11β. The reason of the occurrence of a significant amount of the boat conformer is, similarly to N-methylangustifoline (2), the interaction of an axial allyl group with the bridge H8α hydrogen atom. The smaller fraction of the boat conformation in 5 than in 2 is caused by the repulsion of one of the H14 hydrogen atoms of the allyl group with the axial H5α proton in the boat conformer of 5.     

Chiral self-assembly of methyltin(IV)-naproxenates: Combining dative Sn-O bonds, secondary Sn?O interactions and C-H?O hydrogen bonding to make an inter-helical meander-shaped network and a cross-linked Z-shaped ribbon

Three new chiral organotin(IV) carboxylates, Me₂Sn(nap)₂ (1), {[Me₂Sn(nap)]₂O}₂ (2) and Me₃Sn(nap) (3) (nap = (S)-(+)-6-methoxy-α-methyl-2-naphthaleneaceto anion) have been synthesized. All of them have been characterized by elemental analysis, multinuclear (¹H, ¹³C and ¹¹⁹Sn) NMR and IR spectroscopy. The crystal structures of 1 and 2 have been determined by X-ray diffraction analysis. The bicapped tetrahedral molecules of 1 are linked by C-H?O hydrogen bonds into homochiral helices, which are also interconnected by C-H?O interactions to form an inter-helical meander-shaped network. The molecule of 2 is a parallel double helix incorporating four chiral tin centers in a Sn₄O₁₀C₄ ladder type molecular skeleton. The C-H?O interactions translate the molecular chirality of 2 throughout the crystal via formation of infinite ribbons. These ribbons in their turn are further cross-linked by C-H?O hydrogen bonds. The structural characterization of the complexes 1-3 in solution has been performed by routine multinuclear ¹H, ¹³C and ¹¹⁹Sn NMR as well as specialized multidimensional (¹H-¹¹⁹Sn-gHMQC and ¹H-DOSY) experiments. The relevant ²J_{¹H-¹¹⁹Sn} and ¹J_{¹³C-¹¹⁹Sn} coupling constants have been extracted and related to molecular geometries on the basis of the literature data. The measurement of the translational diffusion constants using diffusion ordered spectroscopy allowed the estimation of the spherical hydrodynamic radii of the newly prepared structures.     

Total synthesis of natural (+)-hyacinthacine A6 and non-natural (+)-7a-epi-hyacinthacine A1 and (+)-5,7a-diepi-hyacinthacine A6

Naturally occurring (1S,2R,3R,5R,7aR)-1,2-dihydroxy-3-hydroxymethyl-5-methylpyrrolizidine [(+)-hyacinthacine A₆, 2] together with unnatural (1S,2R,3R,7aS)-1,2-dihydroxy-3-hydroxymethylpyrrolizidine [(+)-7a-epi-hyacinthacine A₁, 3] and (1S,2R,3R,5S,7aS)-1,2-dihydroxy-3-hydroxymethyl-5-methylpyrrolizidine [(+)-5,7a-diepi-hyacinthacine A₆, 4] have been synthesized from a DALDP derivative [5, (2R,3S,4R,5R)-3,4-dibenzyloxy-2′-O-tert-butyldiphenylsilyl-2,5-bis(hydroxymethyl)pyrrolidine], as the homochiral starting material. The synthetic process employed took advantages of Wittig methodology followed by internal lactamization, in the case of (+)-7a-epi-hyacinthacine A₁ (3), and reductive amination for (+)-hyacinthacine A₆ (2) and (+)-5,7a-diepi-hyacinthacine A₆ (4).     

Total synthesis of (+)-epiepoformin, (+)-epiepoxydon and (+)-bromoxone employing a useful chiral building block, ethyl (1R,2S)-5,5-ethylenedioxy-2-hydroxycyclohexanecarboxylate

Enantioselective total synthesis of (+)-epiepoformin 1, (+)-epiepoxydon 2 and (+)-bromoxone 3 using a chiral building block, ethyl (1R,2S)-5,5-ethylenedioxy-2-hydroxycyclo- hexanecarboxylate 6, is described. Since the synthesis afforded intermediates 18, 2 and 25, it accomplished a formal synthesis of (−)-theobroxide 19, (−)-phyllostine 22, (+)-herveynone 27 and (−)-asperpentyn 28. The usefulness of 6 for the synthesis of natural epoxycyclohexene derivatives was demonstrated.     

Novel synthetic strategy toward abietane and podocarpane-type diterpenes from (−)-sclareol: synthesis of the antitumor (+)-7-deoxynimbidiol

A new route to abietane and podocarpane-type terpenoids from labdane diterpenes is reported. The key step is the transformation of β-ketoester 9 into the corresponding O-acetylsalicylate ester 18, via a manganese(III)-based oxidative free-radical cyclization carried out in Ac₂O. Utilizing this, the synthesis of the antitumor (+)-7-deoxynimbidiol (5) from (−)-sclareol (11) has been achieved. (+)-Nimbidiol (6) and the natural terpenoid 20 have also been synthesized.     

Synthesis, structure and mesomorphic properties of side-chain chiral liquid crystalline polysiloxanes based on (S)-(+)-2-methyl-1-butanol derivatives

The synthesis of five chiral liquid crystalline monomers (M₁-M₅), and their corresponding side-chain polymers (P₁-P₅) based on (S)-(+)-2-methyl-1-butanol derivatives is described. The chemical structures of the monomers were confirmed by FT-IR, ¹H NMR, and elemental analyses. The structure-property relationships of the monomers and polymers obtained are discussed. The mesomorphic properties were investigated by differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), polarizing optical microscopy (POM), and X-ray diffraction (XRD) measurements. All monomers showed a cholesteric phase. For M₂, M₃, and M₅, besides a cholesteric phase and a smectic A (S_A) phase, M₂ also revealed an enantiotropic chiral smectic C phase and a monotropic smectic B (S_B) phase, and M₃ also showed a S_B phase. The polymers P₁-P₅ exhibited a S_A phase, moreover, P₂, P₃ and P₅ also revealed a phase. The experimental results demonstrated that a flexible siloxane backbone and a long flexible spacer tended to exhibit a low glass transition temperature, high thermal stability, and wide mesophase temperature range.     

Asymmetric synthesis of (+)-1-deoxynojirimycin and (+)-castanospermine

Asymmetric total syntheses of (+)-1-deoxynojirimycin (1) and (+)-castanospermine (2) are described. Starting from diene 3, the required absolute stereochemistry is introduced by an asymmetric hydroxylation followed by epoxidation. An intramolecular cyclization of amine 17 gives access to the corresponding tetrasubstituted piperidine 18, which is a precursor to compounds 1 and 2. (+)-Deoxynojirimicyn (1) was obtained in 36% yield over 11 steps from diene 3, while (+)-castanospermine (2) was achieved in 13% after 19 steps from the same starting material.     

Stereoselective total syntheses of (+)-exo- and (−)-exo-brevicomins, (+)-endo- and (−)-endo-brevicomins, (+)- and (−)-cardiobutanolides, (+)-goniofufurone

Stereoselective total syntheses of aggregation pheromones (+)-exo-brevicomin (9a), (−)-exo-brevicomin (9b), (+)-endo-brevicomin (9c), (−)-endo-brevicomin (9d) and styryllactones (+)-cardiobutanolide (14a), (−)-cardiobutanolide (14b), and (+)-goniofufurone (19a) were achieved in good yields from enantiomerically pure highly functionalized furanoid glycal building blocks (1a-d) involving similar synthetic strategies, thus making these furanoid glycals highly useful building blocks in diversity-oriented synthesis (DOS).     

Synthetic applications of homoiodo allylsilane II. Total syntheses of (−)-andrographolide and (+)-rostratone

The first total synthesis of (−)-andrographolide (1), an ent-Labdane diterpenoid lactone from Asian medicinal herb Andrographis paniculata, was achieved via the biomimetic cyclization of an epoxy homoiodo allylsilane precursor 7. Asymmetric total synthesis of (+)-rostratone (25), an antipodal Labdane diterpenoid, was also accomplished via similar biomimetic cyclization of a readily accessible epoxy homoiodo allylsilane precursor 18.     

Polyhydroxylated pyrrolizidines. Part 6: A new and concise stereoselective synthesis of (+)-casuarine and its 6,7-diepi isomer, from DMDP

A new synthesis for (+)-casuarine (1) and its 6,7-diepi isomer (15) in a stereocontrolled manner, is reported herein. An appropriately protected polyhydroxylated pyrrolidine, such as (2R,3R,4R,5R)-3,4-dibenzyloxy-2′-O-tert-butyldiphenylsilyl-2,5-bis(hydroxymethyl)pyrrolidine (3, protected DMDP), easily available from d-fructose, was chosen as the chiral starting material. Compounds 1 and 15 were obtained from 3, in seven steps, in a 23.2 and 20.5% overall yields, respectively.     

A facile synthesis of (6S,1′S)-(+)-hernandulcin and (6S,1′R)-(+)-epihernandulcin

A facile total synthesis of (+)-hernandulcin (1) was accomplished from (−)-isopulegol in 6 steps with 15% overall yield. Epoxidation of (−)-isopulegol with m-chloroperbenzoic acid followed by opening of the epoxide 3a with prenyl Grignard afforded the tertiary alcohol 4a with correct C-6 and C-1′ stereochemistry as a major product. Oxidation of the secondary alcohol in compound 4a to the ketone 5a was accomplished in high yield by using TPAP and N-methylmorpholine N-oxide. Conversion of the ketone 5a to α,β-unsaturated ketone via organoselenium intermediate gave (+)-hernandulcin (1). This method was also successfully applied to the synthesis of (+)-epihernandulcin (2).     

The second generation synthesis of (+)-pseudodeflectusin

The second generation synthesis of (+)-pseudodeflectusin (1), a potential antitumor agent, has been achieved. The key synthetic step is the cascade reaction involving Diels-Alder reaction, lactonization, and decarboxylation to give cycloadduct 6 with complete regioselectivity in good yield. We found that NaH is the best base to facilitate the Diels-Alder reaction of hydroxypyrone 7 with alkyne 8. The present synthetic route enables the total synthesis of (+)-1 in only five-steps from the known compounds 7 and 8.     

Total synthesis of (R)-(+)-goniothalamin and (R)-(+)-goniothalamin oxide: first application of the sulfoxide-modified Julia olefination in total synthesis

A short and efficient synthesis of (R)-(+)-goniothalamin 1 and (R)-(+)-goniothalamin oxide 2 is described. During this approach, the sulfoxide-modified Julia olefination was used as a key step to connect aldehyde 5 to sulfoxide 6. The desired styryl-containing adduct is obtained in good yield and with excellent E/Z selectivity.